Search - tctmd.com

Displaying 961 - 980 of 1273

Sort: Relevancy | Date

Presentation TCT 2017

Real World Evidence: Industry view

Presenter: Daniel A Canos, Kazuhiro Sase, Larry L. Wood

October 30, 2017

Presentation TCT 2017

Real World Evidence: Academic view

Presenter: Daniel A Canos, Kazuhiro Sase, Mitchell W. Krucoff

October 30, 2017

Presentation TCT 2017

Real World Evidence: PMDA view

Presenter: Daniel A Canos, Kazuhiro Sase, Haruki Shirato

October 30, 2017

Presentation TCT 2017

Real World Evidence and The National Evaluation System for health Technologies (NEST): FDA View

Presenter: Daniel A Canos, Kazuhiro Sase

October 30, 2017

Presentation TCT 2017

Japan-USA Endovascular AV Fistula

Presenter: Robert Thatcher, Hiroyoshi Yokoi, Prabir Roy-Chaudhury

October 30, 2017

Presentation TCT 2017

Japan-USA Orbital Atherectomy for Calcific Coronary Lesions

Presenter: Robert Thatcher, Hiroyoshi Yokoi, Brad Martinsen

October 30, 2017

Presentation TCT 2017

Japan-USA Coronary Stent Innovation: EPC Capture

Presenter: Robert Thatcher, Hiroyoshi Yokoi, Stephen Rowland

October 30, 2017

Presentation TCT 2017

Industry Perspective on HBD

Presenter: Fumiaki Ikeno, Yuka Suzuki, Neal Fearnot

October 30, 2017

Presentation TCT 2017

Academic Perspective on HBD

Presenter: Fumiaki Ikeno, Yuka Suzuki, Shigeru Saito

October 30, 2017

Presentation TCT 2017

MHLW/PMDA Perspectives on HBD: Past, Present, and Future

Presenter: Fumiaki Ikeno, Yuka Suzuki, Kiyohito Nakai

October 30, 2017

Presentation TCT 2017

FDA Perspectives on HBD: Past, Present, and Future

Presenter: Fumiaki Ikeno, Yuka Suzuki, Bram D. Zuckerman

October 30, 2017

Presentation TCT 2017

Will Robotic Technology Ever Facilitate Tele-stenting Over Long Geographic Distances?

Presenter: Bernard De Bruyne, Evelyn S. Regar, Ryan D. Madder

October 30, 2017

Presentation TCT 2017

Featured Lecture: Technological Evolution of Cath-lab Technologies: Impact of Advanced Imaging Diagnostics on Procedural Flow and Interventional Procedures

Presenter: Bernard De Bruyne, Evelyn S. Regar, Giora Weisz

October 30, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2017

Shelley Wood

October 29, 2017

News Opinion Fellow Talk

My Picks for Fellows Attending TCT 2017

Amit K. Gupta, MBBS, MD

October 26, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Daily News

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Yael L. Maxwell

October 20, 2017

News Features

Conference Organizers, Physicians Wary as Direct Industry Sponsorship Winds Down in Europe

Todd Neale

October 16, 2017

News Daily News

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Michael O'Riordan

October 11, 2017

News Daily News

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Shelley Wood

October 10, 2017

Advertisement

Real World Evidence: Industry view

Real World Evidence: Academic view

Real World Evidence: PMDA view

Real World Evidence and The National Evaluation System for health Technologies (NEST): FDA View

Japan-USA Endovascular AV Fistula

Japan-USA Orbital Atherectomy for Calcific Coronary Lesions

Japan-USA Coronary Stent Innovation: EPC Capture

Industry Perspective on HBD

Academic Perspective on HBD

MHLW/PMDA Perspectives on HBD: Past, Present, and Future

FDA Perspectives on HBD: Past, Present, and Future

Will Robotic Technology Ever Facilitate Tele-stenting Over Long Geographic Distances?

Featured Lecture: Technological Evolution of Cath-lab Technologies: Impact of Advanced Imaging Diagnostics on Procedural Flow and Interventional Procedures

TCTMD’s Top 10 Most Popular Stories for October 2017

My Picks for Fellows Attending TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Conference Organizers, Physicians Wary as Direct Industry Sponsorship Winds Down in Europe

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content